Q-RNA
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3960 Broadway Ste 407, New York City, Ne...Phone Number
(212) 568-0365Website
www.q-rna.comRevenue
<$5 MillionIndustry
About Q-RNA
Is Q-RNA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Q-RNA launches new products
Check if Q-RNA has recently received funding, and reach out quickly before it becomes old news!
Check out if Q-RNA is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Q-RNA
Website visits: Recent activity has been detected on your website
Q-RNA, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Q-RNA recently announced quarterly report
Click to see if Q-RNA had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Q-RNA has new funding data
Recommended Actions
Find VP level buyers at Q-RNA
Find more new buyers
Compare Similar Companies to Q-RNA
Compare insights from companies similar to Q-RNA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Q-RNA
Company Profile Activity
Activity Insights
Q-RNA is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Q-RNA is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Q-RNA.
Q-RNA Tech Stack
Top Business Services Companies
Frequently Asked Questions Regarding Q-RNA
It is Q-RNA's mission to develop its novel drug target and discovery systems and use them to discover and optimize therapeutics to treat Alzheimer's disease (AD), a disorder with a large unmet medical need. With its initial focus on Alzheimer's disease, the Company will begin with a library of anti-amyloid compounds designed by a former founder of... Read More